Literature DB >> 28942479

Tumor necrosis factor-associated periodic syndrome in adults.

Sharika Gopakumar Menon1, Petros Efthimiou2,3.   

Abstract

Tumor necrosis factor-associated periodic syndrome is an autoinflammatory disorder classified under hereditary periodic fever syndromes. Mutations in the tumor necrosis factor receptor contribute to tumor necrosis factor-associated periodic syndrome. Decreased shedding of receptors and increased mitochondrial reactive oxygen species production leading to elevated proinflammatory cytokines are documented. Inflammation in various organs is hallmark of tumor necrosis factor-associated periodic syndrome and manifests as spiking fever, abdominal pain, conjunctivitis and polyserositis in adults. The ongoing challenge is to diagnose the disease early in its course to prevent amyloidosis. The treatment options have evolved from use of nonsteroidal anti-inflammatory drugs and corticosteroids to targeted therapy like tumor necrosis factor receptor inhibitors and interleukin-1 blockers. The aim of this review is to give an overview of the pathogenesis, clinical features and the various treatment modalities available for tumor necrosis factor-associated periodic syndrome and aid physicians in recognizing the signs of the disease earlier.

Entities:  

Keywords:  Autoinflammatory disorder; Hereditary periodic syndrome; IL-1 blocker; Tumor necrosis factor-associated periodic syndrome

Mesh:

Substances:

Year:  2017        PMID: 28942479     DOI: 10.1007/s00296-017-3820-4

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  97 in total

1.  Treatment of renal amyloidosis with etanercept in tumour necrosis factor receptor-associated periodic syndrome.

Authors:  E Drewe; M L Huggins; A G Morgan; M J D Cassidy; R J Powell
Journal:  Rheumatology (Oxford)       Date:  2004-08-17       Impact factor: 7.580

2.  Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study.

Authors:  Ariel C Bulua; Douglas B Mogul; Ivona Aksentijevich; Harjot Singh; David Y He; Larry R Muenz; Michael M Ward; Cheryl H Yarboro; Daniel L Kastner; Richard M Siegel; Keith M Hull
Journal:  Arthritis Rheum       Date:  2012-03

3.  Efficacy of an interleukin-1β receptor antagonist (anakinra) in idiopathic recurrent pericarditis.

Authors:  Alessandra Scardapane; Antonio Brucato; Francesco Chiarelli; Luciana Breda
Journal:  Pediatr Cardiol       Date:  2012-10-07       Impact factor: 1.655

Review 4.  Amyloidosis in autoinflammatory syndromes.

Authors:  Laura Obici; Giampaolo Merlini
Journal:  Autoimmun Rev       Date:  2012-08-02       Impact factor: 9.754

Review 5.  The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.

Authors:  Vittoria Bascherini; Carmela Granato; Giuseppe Lopalco; Giacomo Emmi; Lorenzo Vannozzi; Daniela Bacherini; Rossella Franceschini; Florenzo Iannone; Annabella Salerni; Francesco Molinaro; Mario Messina; Bruno Frediani; Carlo Selmi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-04-02       Impact factor: 2.980

6.  Myocarditis and sacroiliitis: 2 previously unrecognized manifestations of tumor necrosis factor receptor associated periodic syndrome.

Authors:  Stephanie Trost; Carlos D Rosé
Journal:  J Rheumatol       Date:  2005-01       Impact factor: 4.666

7.  The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.

Authors:  Catherine Dodé; Marc André; Thierry Bienvenu; Pierre Hausfater; Christophe Pêcheux; Jacques Bienvenu; Jean-Claude Lecron; Philippe Reinert; Daniel Cattan; Jean-Charles Piette; Marie-France Szajnert; Marc Delpech; Gilles Grateau
Journal:  Arthritis Rheum       Date:  2002-08

8.  Acute myocarditis and Tumor Necrosis Factor Receptor-Associated Periodic (TRAP) syndrome: first case described and discussion.

Authors:  F Roubille; G Cayla; G Gahide; G Mourad; J C Macia
Journal:  Eur J Intern Med       Date:  2008-09-04       Impact factor: 4.487

9.  Incidence of TNFRSF1A mutations in German children: epidemiological, clinical and genetic characteristics.

Authors:  Elke Lainka; Ulrich Neudorf; Peter Lohse; Christian Timmann; Silvia Stojanov; Kristina Huss; Rudiger von Kries; Tim Niehues
Journal:  Rheumatology (Oxford)       Date:  2009-06-18       Impact factor: 7.580

10.  The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry.

Authors:  H J Lachmann; R Papa; K Gerhold; L Obici; I Touitou; L Cantarini; J Frenkel; J Anton; I Kone-Paut; M Cattalini; B Bader-Meunier; A Insalaco; V Hentgen; R Merino; C Modesto; N Toplak; R Berendes; S Ozen; R Cimaz; A Jansson; P A Brogan; P N Hawkins; N Ruperto; A Martini; P Woo; M Gattorno
Journal:  Ann Rheum Dis       Date:  2013-08-21       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.